Blood group genotyping by high-throughput DNA analysis applied to 356 reagent red blood cell samples

Transfusion

Volumn 51, Issue 1, 2011, Pages 36-42

  Kappler Gratias, Sandrine ^a,b   Peyrard, Thierry ^a,b   Beolet, Marylise ^a,b   Amiranoff, Denise ^a,b   Menanteau, Cécile ^a,b   Dubeaux, Isabelle ^a,b   Rouger, Philippe ^a,b   Cartron, Jean Pierre ^a,b   Pennec, Pierre Yves Le ^a,b   Pham, Bach Nga ^a,b  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b Etablissement Franàais du Sang Haut de France   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIBODY; ERYTHROCYTE ANTIGEN; GENOMIC DNA; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ACCURACY; ANTIBODY SCREENING; ARTICLE; BLOOD CELL; BLOOD DONOR; BLOOD GROUP; BLOOD GROUP DO SYSTEM; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP LUTHERAN SYSTEM; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP SYSTEM; BLOOD GROUP TYPING; BLOOD RHEOLOGY; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; DNA FINGERPRINTING; DONOR SELECTION; ERYTHROCYTE; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; NORMAL HUMAN; PANEL STUDY; PHENOTYPE; SEROLOGY;

BLOOD GROUP ANTIGENS; ERYTHROCYTES; GENOTYPE; HUMANS; SEQUENCE ANALYSIS, DNA;

EID: 78651369197     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02802.x     Document Type: Article

References (34)

1. Arrêté du 26 Avril 2002 published in Journal Officiel de la République Francaise n°104 du 4 mai 2002 page 8375, texte n°80.
2. Daniels G,. The molecular genetics of blood group polymorphism. Hum Genet 2009; 126: 729-42.
3. Reid ME, Lomas-Francis C,. The blood group antigen factsbook. 2nd ed. San Diego (CA); London: Academic; 2004.
4. Veldhuisen B, van der Schoot CE, de Haas M,. Blood group genotyping: from patient to high-throughput donor screening. Vox Sang 2009; 97: 198-206.
5. Ansart-Pirenne H, Martin-Blanc S, Le Pennec PY, Rouger P, Cartron JP, Tournamille C,. FY X real-time polymerase chain reaction with melting curve analysis associated with a complete one-step real-time FY genotyping. Vox Sang 2007; 92: 142-7.
6. Araujo F, Pereira C, Aleixo A, Henriques I, Monteiro F, Meireles E, Lacerda P, Cunha-Ribeiro LM,. Rapid genotyping of the major alleles at the Duffy (FY) blood group locus using real-time fluorescence polymerase chain reaction. Immunohematology 2001; 17: 42-4.
7. Araujo F, Pereira C, Monteiro F, Henriques I, Meireles E, Lacerda P, Aleixo A, Rodrigues MJ, Celeste R, Cunha-Ribeiro LM,. Blood group antigen profile predicted by molecular biology-use of real-time polymerase chain reaction to genotype important KEL, JK,RHD, and RHCE alleles. Immunohematology 2002; 18: 59-64.
8. Hue-Roye K, Vege S,. Principles of PCR-based assays. Immunohematology 2008; 24: 170-5.
9. Mullis KB,. The unusual origin of the polymerase chain reaction. Sci Am 1990; 262: 56-61, 4- 5.
10. Mullis KB, Faloona FA,. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987; 155: 335-50.
11. Tournamille C, Le Van Kim C, Gane P, Cartron JP, Colin Y,. Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism. Hum Genet 1995; 95: 407-10.
12. Avent ND,. Large-scale blood group genotyping: clinical implications. Br J Haematol 2009; 144: 3-13.
13. Avent ND, Martinez A, Flegel WA, Olsson ML, Scott ML, Nogues N, Pisacka M, Daniels G, van der Schoot E, Muniz-Diaz E, Madgett TE, Storry JR, Beiboer SH, Maaskant-van Wijk PA, von Zabern I, Jimenez E, Tejedor D, Lopez M, Camacho E, Cheroutre G, Hacker A, Jinoch P, Svobodova I, de Haas M,. The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond. Transfusion 2007; 47: 40S-6S.
14. Hopp K, Weber K, Bellissimo D, Johnson ST, Pietz B,. High-throughput red blood cell antigen genotyping using a nanofluidic real-time polymerase chain reaction platform. Transfusion 50: 40-6.
15. Ribeiro KR, Guarnieri MH, da Costa DC, Costa FF, Pellegrino J, Jr, Castilho L,. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sang 2009; 97: 147-52.
16. Montpetit A, Phillips MS, Mongrain I, Lemieux R, St-Louis M,. High-throughput molecular profiling of blood donors for minor red blood cell and platelet antigens. Transfusion 2006; 46: 841-8.
17. Karpasitou K, Drago F, Crespiatico L, Paccapelo C, Truglio F, Frison S, Scalamogna M, Poli F,. Blood group genotyping for Jk(a)/Jk(b), Fy(a)/Fy(b), S/s, K/k, Kp(a)/Kp(b), Js(a)/Js(b), Co(a)/Co(b), and Lu(a)/Lu(b) with microarray beads. Transfusion 2008; 48: 505-12.
18. Hashmi G,. Red blood cell antigen phenotype by DNA analysis. Transfusion 2007; 47: 60S-3S.
19. Hashmi G, Shariff T, Seul M, Vissavajjhala P, Hue-Roye K, Charles-Pierre D, Lomas-Francis C, Chaudhuri A, Reid ME,. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005; 45: 680-8.
20. Hashmi G, Shariff T, Zhang Y, Cristobal J, Chau C, Seul M, Vissavajjhala P, Baldwin C, Hue-Roye K, Charles-Pierre D, Lomas-Francis C, Reid ME,. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion 2007; 47: 736-47.
21. Denomme GA, Van Oene M,. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 2005; 45: 660-6.
22. Tournamille C, Le Van Kim C, Gane P, Le Pennec PY, Roubinet F, Babinet J, Cartron JP, Colin Y,. Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Blood 1998; 92: 2147-56.
23. Tournamille C, Colin Y, Cartron JP, Le Van Kim C,. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995; 10: 224-8.
24. Hult A, Hellberg A, Wester ES, Olausson P, Storry JR, Olsson ML,. Blood group genotype analysis for the quality improvement of reagent test red blood cells. Vox Sang 2005; 88: 265-70.
25. Storry JR, Olsson ML, Reid ME,. Application of DNA analysis to the quality assurance of reagent red blood cells. Transfusion 2007; 47: 73S-8S.
26. Zimmerman PA, Woolley I, Masinde GL, Miller SM, McNamara DT, Hazlett F, Mgone CS, Alpers MP, Genton B, Boatin BA, Kazura JW,. Emergence of FY A(null) in a Plasmodium vivax-endemic region of Papua New Guinea. Proc Natl Acad Sci U S A 1999; 96: 13973-7.
27. Shimizu Y, Kimura M, Settheetham-Ishida W, Duangchang P, Ishida T,. Serotyping of Duffy blood group in several Thai ethnic groups. Southeast Asian J Trop Med Public Health 1997; 28: 32-5.
28. Chapman JF, Elliott C, Knowles SM, Milkins CE, Poole GD,. Guidelines for compatibility procedures in blood transfusion laboratories. Transfus Med 2004; 14: 59-73.
29. Issitt PD, Anstee DJ,. Antibody detection and identification, and compatybility testing. In:, Issitt PD, Anstee DJ, editors. Applied blood group serology. 4th ed. Durham (NC): Montgomery Scientific Publications; 1998. p. 873-905.
30. U.S. Food and Drug Administration. Additional standards for diagnostic substances for laboratory tests. 2006. [cited 2006 Apr]. Available from: URL
31. Brecher ME,. Technical manual. 15th ed. Bethesda (MD): American Association of Blood Banks; 2005.
32. Flegel WA, Wagner FF,. RHD epitope density profiles of RHD variant red cells analyzed by flow cytometry. Transfus Clin Biol 1996; 3: 429-31.
33. Jones JW, Lloyd-Evans P, Kumpel BM,. Quantitation of Rh D antigen sites on weak D and D variant red cells by flow cytometry. Vox Sang 1996; 71: 176-83.
34. Chester MA, Olsson ML,. The ABO blood group gene: a locus of considerable genetic diversity. Transfus Med Rev 2001; 15: 177-200.